Forty-four patients ( @ % ) in the antiarrhythmic group and in @ patients ( @ % ) in the ablation group experienced the primary efficacy outcome ( hazard ratio -LSB- HR -RSB- , @ -LSB- @ % CI , @-@ @ -RSB- ; P = @ ) .